As of April 18, 2025, Longboard Pharmaceuticals (LBPH) has a market cap of $2.34 billion USD. According to our data, Longboard Pharmaceuticals is ranked No.3753 in global market value.
Year | Market Cap | %Change |
---|---|---|
Dec 13, 2024 | $2.34 B |
894.69%
|
Dec 29, 2023 | $0.21 B |
84.97%
|
Dec 30, 2022 | $0.11 B |
-33.20%
|
Dec 31, 2021 | $0.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.09 B |
-0.000 M
|
![]() USA
|
![]() Biohaven Pharmaceutical
BHVN
|
$2.08 B |
0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.46 B |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.45 B |
-0.000 M
|
![]() Ireland
|
![]() Corcept Therapeutics
CORT
|
$6.57 B |
0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.72 B |
-0.000 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$10.03 B |
-0.000 M
|
![]() USA
|
![]() Marinus Pharmaceuticals
MRNS
|
$30.37 M |
0.028 M
|
![]() USA
|
![]() Minerva Neurosciences
NERV
|
$11.19 M |
0.000 M
|
![]() USA
|
![]() Ovid Therapeutics
OVID
|
$20.51 M |
0.000 M
|
![]() USA
|
![]() Cassava Sciences
SAVA
|
$69.56 M |
-0.000 M
|
![]() USA
|
![]() Anavex Life Sciences
AVXL
|
$0.76 B |
-0.000 M
|
![]() USA
|
Market Cap | = | LBPH Stock Price | * | LBPH Shares Outstanding |
= | $59.98 | * | 34.44 M | |
= | $2.34 B |